InBody Co

InBody Co Equity

The The Equity of InBody Co (041830.KQ) as of Oct 27, 2026 is 317.85 B KRW. In the previous year, The Equity was 272.97 B KRW — a change of 16.44% (higher).

Equity

317.85 BKRW

YoY

16.44%

Last updated:

In 2025, InBody Co's equity was 317.85 B KRW, a 16.44% increase from the 272.97 B KRW equity in the previous year.

The InBody Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
124.39 B KRW
Jan 1, 2019
139.69 B KRW
Jan 1, 2020
150.06 B KRW
Jan 1, 2021
183.73 B KRW
Jan 1, 2022
215.26 B KRW
Jan 1, 2023
248.77 B KRW
Jan 1, 2024
272.97 B KRW
Jan 1, 2025
317.85 B KRW
The InBody Co Equity history
YEAREquityYoY
317.85 BKRW+16.44%
272.97 BKRW+9.73%
248.77 BKRW+15.57%
215.26 BKRW+17.16%
183.73 BKRW+22.44%
150.06 BKRW+7.43%
139.69 BKRW+12.31%
124.39 BKRW+16.82%
106.48 BKRW+15.36%
92.30 BKRW+20.94%
76.32 BKRW+28.08%
59.58 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing InBody Co's Equity

InBody Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding InBody Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating InBody Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

InBody Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in InBody Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about InBody Co stock

The Equity of InBody Co is 317.85 B KRW in 2025.

The Equity of InBody Co changed from 272.97 B KRW to 317.85 B KRW, representing a 16.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity InBody Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's InBody Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — InBody Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — InBody Co